Latham & Watkins represented Spectrum Pharmaceuticals in the deal.Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, has entered into a…
Spectrum Pharmaceuticals’ $65 Million Debt Financing Agreement With SLR Capital Partners
![](https://globallegalchronicle.com/wp-content/uploads/2022/09/spectrum-pharmaceuticals-65-million-debt-financing-agreement-with-slr-capital-partners_6336a1fc09868.jpeg)